Skip to main content

Your Money or Your Meds

Premium

Cancer research is moving on stronger than ever, and pharmaceutical companies and biotechs are finding new treatments, says Katherine Hobson at the Wall Street Journal's Health Blog. But those innovations come with a price — cancer drugs are expensive, and the cost keeps going up. Assuming there will be no changes in pricing trends, NCI estimates medical costs due to cancer will hit $158 billion in 2020, and could even go as high as $207 billion, Hobson says. A recent study published jointly by the Journal of Oncology Practice and the American Journal of Managed Care found that 10 percent of patients failed to fill new prescriptions for oral cancer drugs, and experts say it's partly because of the cost to patients, she adds. The study's authors say policymakers need to find ways to lower the cost of cancer prescriptions for patients so that there's no barrier to their receiving the best care possible.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.